Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,405 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study.
Qi SN, Yang Y, Zhang YJ, Huang HQ, Wang Y, He X, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Qiao XY, Wang H, Li GF, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Xu LM, Yuan ZY, Su H, Song YQ, Zhu J, Hu C, Li YX. Qi SN, et al. Among authors: wu g, wu jx, wu t. Am J Hematol. 2020 Sep;95(9):1047-1056. doi: 10.1002/ajh.25878. Epub 2020 Jul 16. Am J Hematol. 2020. PMID: 32449800 Free article. Clinical Trial.
Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy.
Zheng B, Zhu X, Liu M, Yang Z, Yang L, Lang J, Shi M, Wu G, He X, Chen X, Xi X, Zhao D, Zhu G. Zheng B, et al. Among authors: wu g. Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):418-426. doi: 10.1016/j.ijrobp.2017.10.013. Epub 2017 Oct 13. Int J Radiat Oncol Biol Phys. 2018. PMID: 29353657
Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).
Deng XW, Wu JX, Wu T, Zhu SY, Shi M, Su H, Wang Y, He X, Xu LM, Yuan ZY, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Zhang YJ, Zhu Y, Cao JZ, Lan SM, Dong M, Qi SN, Yang Y, Li YX. Deng XW, et al. Among authors: wu jx, wu g, wu t. Radiother Oncol. 2018 Oct;129(1):3-9. doi: 10.1016/j.radonc.2018.04.026. Epub 2018 May 5. Radiother Oncol. 2018. PMID: 29739712
Nedaplatin Plus Docetaxel Versus Cisplatin Plus Docetaxel as First-Line Chemotherapy for Advanced Squamous Cell Carcinoma of the Lung - A Multicenter, Open-label, Randomized, Phase III Trial.
Lu S, Chen Z, Hu C, Zhang J, Chen Y, Song Y, Zhao Q, Fan Y, Wu G, Ma Z, Fang J, Yu Q, Liu Z. Lu S, et al. Among authors: wu g. J Thorac Oncol. 2018 Nov;13(11):1743-1749. doi: 10.1016/j.jtho.2018.07.006. Epub 2018 Jul 11. J Thorac Oncol. 2018. PMID: 30017831 Free article. Clinical Trial.
Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group.
Wu T, Yang Y, Zhu SY, Shi M, Su H, Wang Y, He X, Xu LM, Yuan ZY, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Zhang YJ, Zhu Y, Cao JZ, Lan SM, Wu JX, Hu C, Qi SN, Chen B, Li YX. Wu T, et al. Among authors: wu g, wu jx. Blood Adv. 2018 Sep 25;2(18):2369-2377. doi: 10.1182/bloodadvances.2018021311. Blood Adv. 2018. PMID: 30242098 Free PMC article.
17,405 results
You have reached the last available page of results. Please see the User Guide for more information.